AU2001256780A1 - Method for examining ischemic conditions - Google Patents

Method for examining ischemic conditions

Info

Publication number
AU2001256780A1
AU2001256780A1 AU2001256780A AU5678001A AU2001256780A1 AU 2001256780 A1 AU2001256780 A1 AU 2001256780A1 AU 2001256780 A AU2001256780 A AU 2001256780A AU 5678001 A AU5678001 A AU 5678001A AU 2001256780 A1 AU2001256780 A1 AU 2001256780A1
Authority
AU
Australia
Prior art keywords
examining
ischemic conditions
ischemic
conditions
examining ischemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256780A
Inventor
Satoshi Asai
Yukimoto Ishii
Koichi Ishikawa
Toshihito Nagata
Yasuo Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIHON UNIVERSITY SCHOOL JURIDICAL PERSON
Original Assignee
SCHOOL JURIDICAL PERSON NIHON
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHOOL JURIDICAL PERSON NIHON filed Critical SCHOOL JURIDICAL PERSON NIHON
Publication of AU2001256780A1 publication Critical patent/AU2001256780A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
AU2001256780A 2000-05-18 2001-05-18 Method for examining ischemic conditions Abandoned AU2001256780A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-145977 2000-05-18
JP2000145977 2000-05-18
PCT/JP2001/004192 WO2001088188A2 (en) 2000-05-18 2001-05-18 Method for examining ischemic conditions

Publications (1)

Publication Number Publication Date
AU2001256780A1 true AU2001256780A1 (en) 2001-11-26

Family

ID=18652408

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256780A Abandoned AU2001256780A1 (en) 2000-05-18 2001-05-18 Method for examining ischemic conditions

Country Status (3)

Country Link
JP (1) JP2004512014A (en)
AU (1) AU2001256780A1 (en)
WO (1) WO2001088188A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1573024A4 (en) 2001-04-10 2007-08-29 Agensys Inc Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
CA2443147A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
WO2003002606A2 (en) * 2001-06-29 2003-01-09 Decode Genetics Ehf. Nucleic acids encoding ion channels
AU2003901511A0 (en) * 2003-03-28 2003-04-17 Bionomics Limited Nucleic acid molecules associated with angiogenesis II
EP1704224A4 (en) * 2003-12-16 2008-03-12 Joshua M Hare Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy
EP1795609A1 (en) * 2005-12-06 2007-06-13 Sanofi-Aventis Deutschland GmbH Method for the diagnosis and treatment of cardiovascular diseases
EP2408905B1 (en) 2009-03-16 2017-05-10 Pangu Biopharma Limited Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
EP2939689B1 (en) 2009-12-11 2017-09-13 aTyr Pharma, Inc. Glutaminyl tRNA synthetases for use in the treatment of inflammatory disorders
CN103118692A (en) 2010-04-26 2013-05-22 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
AU2011248614B2 (en) 2010-04-27 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
CA2797259C (en) 2010-04-27 2020-09-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
CN103097524B (en) 2010-04-28 2016-08-03 Atyr医药公司 The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Alanyl-tRNA synthetase finds
CN103118693B (en) 2010-04-29 2017-05-03 Atyr 医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
US8986680B2 (en) 2010-04-29 2015-03-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
EP2566496B1 (en) 2010-05-03 2018-02-28 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
EP2566495B1 (en) 2010-05-03 2017-03-01 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
EP2566515B1 (en) 2010-05-03 2017-08-02 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
JP6039546B2 (en) 2010-05-03 2016-12-07 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of seryl tRNA synthetase
AU2011248101B2 (en) 2010-05-04 2016-10-20 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
CA2798301C (en) 2010-05-04 2020-09-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases
CA2799197C (en) 2010-05-14 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
EP2575856B1 (en) 2010-05-27 2017-08-16 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
EP2575857B1 (en) 2010-06-01 2018-01-24 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
JP6116479B2 (en) 2010-07-12 2017-04-19 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glycyl-tRNA synthetase
KR20130102534A (en) 2010-07-12 2013-09-17 에이티와이알 파마, 인코포레이티드 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
AU2011279392C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases
US9029506B2 (en) 2010-08-25 2015-05-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases
EP2616484B1 (en) 2010-09-15 2017-10-25 Universiteit Leiden Screening method
JP6039566B2 (en) 2010-10-06 2016-12-07 エータイアー ファーマ， インコーポレイテッド Innovative discovery of tryptophanyl tRNA synthetase protein fragments related to therapeutic, diagnostic and antibody compositions
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
US9688978B2 (en) 2011-12-29 2017-06-27 Atyr Pharma, Inc. Aspartyl-tRNA synthetase-Fc conjugates
RU2659423C2 (en) 2012-02-16 2018-07-02 ЭйТИР ФАРМА, ИНК. Hystidil-trna-synthetase for treatment of autoimmune and inflammatory diseases
CN105378075B (en) 2013-03-15 2022-04-05 Atyr 医药公司 Histidyl-TRNA synthetase-FC conjugates
WO2017046084A1 (en) 2015-09-15 2017-03-23 Friedrich Miescher Institute For Biomedical Research Novel therapeutical tools and methods for treating blindness by targeting photoreceptors
WO2017197141A2 (en) * 2016-05-13 2017-11-16 Sangamo Therapeutics, Inc. Targeted treatment of androgenic alopecia
EP3612215A4 (en) 2017-04-20 2021-05-26 aTyr Pharma, Inc. Compositions and methods for treating lung inflammation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1630501A (en) * 1999-10-08 2001-04-23 Superarray, Inc. Compositions and methods for detecting protein modification and enzymatic activity

Also Published As

Publication number Publication date
WO2001088188A3 (en) 2003-06-12
JP2004512014A (en) 2004-04-22
WO2001088188A2 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU2001256780A1 (en) Method for examining ischemic conditions
AU2651701A (en) Method for introducing additives
AU2002224154A1 (en) Method for producing polybutene
AU2001263887A1 (en) Monitoring method
AUPQ540900A0 (en) Apparatus for composting
AU2001227140A1 (en) Method for inhibiting apoptosis under ischemic condition
AU2002213972A1 (en) Method for producing polyisobutenylphenoles
AU2001273694A1 (en) Method for changing color
AU2001233699A1 (en) Method for selecting products
AU2001287822A1 (en) Method for tensioning multiple-strand cables
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001220281A1 (en) Rollerboard for road-skiing
AU5650401A (en) Method for enhancing cognitive function
AU2001295036A1 (en) Apparatus for performing microcurrentelectrotherapy
AU2001237530A1 (en) Method
AUPQ933100A0 (en) Apparatus for welding
AU6435301A (en) Method for making polypyrrole
AU2001258827A1 (en) Method for examining WT1-related disease
AU2001241636A1 (en) Halotherapy method
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001267403A1 (en) Method for examining macromolecules
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU2001259161A1 (en) Method for making polyimide
AU2000234538A1 (en) Printing method